Bridgewater Associates’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,100
| Closed | -$298K | – | 890 |
|
2024
Q1 | $298K | Sell |
1,100
-1,665
| -60% | -$451K | ﹤0.01% | 655 |
|
2023
Q4 | $654K | Sell |
2,765
-240
| -8% | -$56.7K | ﹤0.01% | 679 |
|
2023
Q3 | $589K | Sell |
3,005
-1,301
| -30% | -$255K | ﹤0.01% | 674 |
|
2023
Q2 | $905K | Buy |
4,306
+1,124
| +35% | +$236K | 0.01% | 586 |
|
2023
Q1 | $642K | Sell |
3,182
-263
| -8% | -$53.1K | ﹤0.01% | 614 |
|
2022
Q4 | $751K | Buy |
3,445
+1,392
| +68% | +$303K | ﹤0.01% | 677 |
|
2022
Q3 | $404K | Sell |
2,053
-3,553
| -63% | -$699K | ﹤0.01% | 798 |
|
2022
Q2 | $1.2M | Buy |
5,606
+666
| +13% | +$143K | 0.01% | 769 |
|
2022
Q1 | $1.4M | Buy |
4,940
+3,453
| +232% | +$981K | 0.01% | 755 |
|
2021
Q4 | $560K | Buy |
1,487
+838
| +129% | +$316K | ﹤0.01% | 637 |
|
2021
Q3 | $268K | Buy |
+649
| New | +$268K | ﹤0.01% | 647 |
|
2019
Q4 | – | Sell |
-3,406
| Closed | -$451K | – | 499 |
|
2019
Q3 | $451K | Buy |
+3,406
| New | +$451K | ﹤0.01% | 283 |
|
2019
Q1 | – | Sell |
-15,166
| Closed | -$1.72M | – | 354 |
|
2018
Q4 | $1.72M | Buy |
15,166
+12,120
| +398% | +$1.37M | 0.02% | 261 |
|
2018
Q3 | $410K | Sell |
3,046
-7,459
| -71% | -$1M | ﹤0.01% | 298 |
|
2018
Q2 | $1.18M | Sell |
10,505
-1,740
| -14% | -$195K | 0.01% | 235 |
|
2018
Q1 | $1.31M | Buy |
+12,245
| New | +$1.31M | 0.01% | 236 |
|
2017
Q4 | – | Sell |
-2,574
| Closed | -$278K | – | 265 |
|
2017
Q3 | $278K | Sell |
2,574
-4,135
| -62% | -$447K | ﹤0.01% | 275 |
|
2017
Q2 | $679K | Buy |
+6,709
| New | +$679K | 0.01% | 233 |
|
2016
Q1 | – | Sell |
-2,687
| Closed | -$216K | – | 268 |
|
2015
Q4 | $216K | Sell |
2,687
-17,000
| -86% | -$1.37M | ﹤0.01% | 254 |
|
2015
Q3 | $1.25M | Buy |
+19,687
| New | +$1.25M | 0.02% | 222 |
|
2015
Q2 | – | Sell |
-4,700
| Closed | -$373K | – | 330 |
|
2015
Q1 | $373K | Sell |
4,700
-500
| -10% | -$39.7K | ﹤0.01% | 264 |
|
2014
Q4 | $331K | Buy |
5,200
+1,000
| +24% | +$63.7K | ﹤0.01% | 278 |
|
2014
Q3 | $251K | Buy |
+4,200
| New | +$251K | ﹤0.01% | 339 |
|